Literature DB >> 23948939

The Cleveland Clinic Lou Ruvo Center for Brain Health: keeping memory alive.

Jeffrey Cummings1, Kate Zhong, Charles Bernick.   

Abstract

The Cleveland Clinic Lou Ruvo Center for Brain Health (LRCBH) is a unique clinical and translational research enterprise that stems from the passion of Larry Ruvo to honor his father, Lou, a victim of Alzheimer's disease (AD). To attract national attention to AD, Mr. Ruvo convinced architect Frank Gehry to construct the remarkable building complex of the LRCBH in Las Vegas, Nevada. Cleveland Clinic assumed responsibility for running the clinical and research aspects of the LRCBH. The care provided in this novel architectural setting is innovative and emphasizes patients first care with integration of caregiver programs and clinical research opportunities. Standardization of care, outcomes measures, and process metrics provide a platform for assessing, studying, and exporting best practices in cognitive care. Clinical trials empower patients to help solve the diseases that afflict them. The combination of a passionate founder, dramatic architecture, clinical excellence, integrated care partner programs, and commitment to development of next generation treatments makes the LRCBH a unique model of integrated care and research.

Entities:  

Keywords:  Alzheimer's disease; Frank Gehry; Lou Ruvo center for brain health; cleveland clinic; clinical trials

Mesh:

Year:  2014        PMID: 23948939     DOI: 10.3233/JAD-130791

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  4 in total

1.  Thermodynamic and kinetic design principles for amyloid-aggregation inhibitors.

Authors:  Thomas C T Michaels; Andela Šarić; Georg Meisl; Gabriella T Heller; Samo Curk; Paolo Arosio; Sara Linse; Christopher M Dobson; Michele Vendruscolo; Tuomas P J Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-14       Impact factor: 11.205

Review 2.  Neuroscience learning from longitudinal cohort studies of Alzheimer's disease: Lessons for disease-modifying drug programs and an introduction to the Center for Neurodegeneration and Translational Neuroscience.

Authors:  Justin B Miller; Jeffrey Cummings; Christin Nance; Aaron Ritter
Journal:  Alzheimers Dement (N Y)       Date:  2018-07-11

3.  The price of progress: Funding and financing Alzheimer's disease drug development.

Authors:  Jeffrey Cummings; Carl Reiber; Parvesh Kumar
Journal:  Alzheimers Dement (N Y)       Date:  2018-06-13

4.  Neurodegeneration research: Advances in clinical translational neuroscience infrastructure and methods.

Authors:  Jeffrey L Cummings; Nadia Fulkerson
Journal:  Alzheimers Dement (N Y)       Date:  2018-06-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.